Insider filing · SLSN

Bradford T Whitmore bought $28.1M of Solesence (SLSN)

Executed May 29 2025, disclosed Jun 2 2025, 4 days later.

Over the 21 trading sessions from the disclosed entry session (Jun 2 2025), the stock returned +12.1% (delay-adjusted); from the execution session (May 29 2025), +5.1%. Derived: entry at the session's open, exit at the close 20 sessions later.

BW Bradford T Whitmore Director profile →

Bradford T Whitmore (Director) filed 4 Form 4 reports in the trailing twelve months (4 purchases, 0 sales), most often in Ultralife Corporation (ULBI). Across 4 priced purchase filings, the average 21-session return was +15.5% from execution and +11.8% from disclosure (delay-adjusted; derived). The largest single filing was $1.2M of ULBI (187,512 sh across 3 lots, as filed), executed Mar 12.

SLSN SLSN SLSN · 1 filing in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→